ITGAM and neoplasm: An inflammatory response induced by inhibition of VEGF-signalling, and the subsequent recruitment of bone marrow derived cells such as CD11b+ Gr-1+ myeloid cells to the tumour microenvironment has been described as a resistance mechanism for VEGF-signaling inhibitors [24]–[26].